Basic info
Industry
pharmaceutical manufacturing
Sectors
Innovation Management
Biotechnology
GMP Peptides
Commercial Peptide Manufacturing
Process Development
Peptides
Biochemicals
Cosmetic Peptides
Peptide Active Pharmaceutical Ingredients (APIs)
Clinical Peptides
NCE peptides
Analytical Methods Support
Regulatory Support
NCEs
Agricultural peptides
Preclinical Manufacturing
GMP Peptide Manufacturing
Peptide Contract Development & Manufacturing Organization (CDMO)
Custom Peptide Synthesis
Generic Peptides
Manufacturing
Date founded
2005
Funding rounds raised
Total raised
$24M
from 2 investors over 2 rounds
A
AmbioPharm - A Global Peptide CDMO raised undisclosed on September 10, 2018
Investors: The Carlyle Group
A
AmbioPharm - A Global Peptide CDMO raised $24M on November 19, 2014
Investors: MVM Partners